Skip to main content

Table 2 Assessment of pain and use of analgesics

From: Use of analgesics in acute stroke patients with inability to self-report pain: a retrospective cohort study

 

AC

P-NAC

S-NAC

p-value

Number of patients, n (%)

746 (86.6)

25 (2.9)

90 (10.5)

 

Assessment of pain

 Any, n (%), documented by nurses

741 (99.5)

25 (100.0)

89 (98.9)

n.s.

 Any, n (%), documented by physicians

161 (21.6)

13 (52.0)

57 (63.3)

< 0.001ab

 NRS, n (%)

738 (99.1)

25 (100.0)

85 (94.4)

< 0.012b

 NRS, frequency, n per day (SD)

2.44 (1.10)

2.02 (1.33)

1.68 (0.96)

n.s.

Pain prevalence

 Total, n (%)

353 (47.3)

11 (44.0)

38 (42.2)

n.s.

 Headache, n (%)

188 (25.2)

4 (16.0)

10 (11.1)

0.008b

 Musculoskeletal pain, n (%)

82 (11.0)

1 (4.0)

13 (14.4)

n.s.

 Chronic pain syndrome, n (%)

36 (4.8)

0 (0.0)

1 (1.1)

n.s.

 Not specified, n (%)

199 (26.7)

7 (28.0)

26 (28.9)

n.s.

Use of analgesics

 Any analgesic, n (%)

363 (48.7)

19 (76.0)

70 (77.8)

< 0.001ab

 Opioid, n (%)

54 (7.2)

5 (20.0)

16 (17.8)

0.001ab

 Non-Opioid, n (%)

278 (37.3)

11 (44.0)

56 (62.2)

< 0.001b

 Co-analgesic, n (%)

165 (22.1)

13 (52.0)

21 (23.3)

0.002ac

Indication

 Acute or chronic pain, n (%)

245 (32.8)

3 (12.0)

22 (24.4)

0.029a

 Prophylactic treatment, n (%)

3 (0.4)

5 (20.0)

13 (14.4)

< 0.001ab

 Not documented, n (%)

64 (8.6)

5 (20.0)

18 (20.0)

0.001b

 Other, n (%)

148 (19.8)

15 (60.0)

43 (47.8)

0.000ab

Documented response to treatment, n/n (%)

120/245 (49.0)

1/3 (33.3)

2/22 (9.1)

< 0.001b

  1. a, significant group difference AC vs P-NAC
  2. b, significant group difference AC vs S-NAC
  3. c, significant group difference P-NAC vs S-NAC